Bicara Therapeutics Inc. · NASDAQ:BCAX
T. Rowe Price Investment Management, Inc. reported a 5.90% stake in Bicara Therapeutics Inc. (Schedule 13G)
Event Dec 31, 2025 · Filed Feb 17, 2026
T. Rowe Price Investment Management, Inc. reported a 5.90% stake in Bicara Therapeutics Inc., 3,236,595 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G).
- Stake
- 5.90%
- Shares
- 3,236,595
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 5.90% | 3,236,595 |
Source
Related
- Bicara Therapeutics Inc.
- T. Rowe Price Investment Management, Inc.
- Bicara Therapeutics Inc. shareholders
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Oct 7, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Apr 8, 2026
- Form 4 · Cohlhepp Ryan · Sep 10, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Hyep Ivan · Aug 12, 2026
- Form 4 · Mazumdar Claire · Aug 12, 2026
- Form 4 · Cohlhepp Ryan · Aug 12, 2026